Evidence Lacking for Cannabinoid Use in Children With Cancer
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 30, 2023 -- There is a lack of evidence regarding the dosing, safety, and efficacy of cannabinoids for children with cancer, according to a review published online Aug. 28 in Cancer.
Manik Chhabra, Pharm.D., from the University of Manitoba in Winnipeg, Canada, and colleagues conducted a systematic review to appraise the existing published literature for cannabis product use in children with cancer. A total of 19 unique studies with 1,927 participants with cancer were included: eight retrospective chart reviews, seven randomized controlled trials, two open-label studies, and two case reports.
The researchers found that the studies reported use of various cannabis products for symptom management. Eleven of the studies (58 percent) reported use of cannabinoids for the management of chemotherapy-induced nausea and vomiting. Somnolence, dizziness, dry mouth, and withdrawal due to adverse events were more commonly associated with use of cannabinoids in controlled studies. No serious cannabis-related adverse events were reported across any of the included studies.
"Data are lacking on cannabinoids' effects on pain, mood, sleep, and health-related quality of life," coauthor Lauren E. Kelly, Ph.D., also from the University of Manitoba, said in a statement. "Given that some children report benefits and some children experience adverse events, it is critical that more rigorous studies evaluating the effects of cannabinoids on children with cancer are conducted and shared with parents, patients, and the health care community."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
American Psychiatric Association, May 4-8
The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...
Number, Size of Seizures of Fentanyl Increasing in the United States
MONDAY, May 13, 2024 -- The number and size of seizures of fentanyl are increasing in the United States, with most seizures occurring in the West, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.